Published in Medical Letter on the CDC and FDA, September 22nd, 2002
The FDA's "statement of interest" brief asked U.S. District Judge Mariana Pfaelzer to rescind a decision that grew out of a civil lawsuit. FDA officials said they were worried the ruling improperly interferes with the way the agency regulates drugs and drug companies.
"The FDA is concerned about the ruling," agency spokesman Lawrence Bachorik said. "This is not about a single product or a single company but about FDA's authority over prescription drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.